The Long-term Efficacy and Safety of Nilotinib in Pediatric Patients With CML: a 5-Year Update of the DIALOG Study.

Creative Commons License

Hijiya N., Maschan A., Rizzari C., Shimada H., Dufour C., Goto H., ...Daha Fazla

Blood advances, 2023 (SCI-Expanded) identifier